Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

QIAGEN NV buy Wolfe Research

QIAGEN NV
Start price
€40.47
27.06.24 / 50%
Target price
€46.64
27.06.25
Performance (%)
-
End price
-
28.06.25
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
QIAGEN NV - - -
iShares Core DAX® 0.437% 5.897% 8.047%
iShares Nasdaq 100 1.057% 0.920% 28.466%
iShares Nikkei 225® 1.769% 1.228% 47.574%
iShares S&P 500 0.368% 1.920% 23.200%

Comments by Wolfe_Research for this prediction

In the thread QIAGEN NV diskutieren
Prediction Buy
Perf. (%) -
Target price 46.635
Change
Ends at 27.06.25

Qiagen (NYSE: QGEN) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $50.00 price target on the stock.
Ratings data for QGEN provided by MarketBeat

Wolfe Research 
0
Report Share
27.06.24
In the thread Trading QIAGEN NV
Prediction Buy
Perf. (%) -
Target price 46.635
Change
Ends at 27.06.25

Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten

Wolfe Research 
0
Report Share
28.06.25